Coagulation Monitoring

CoaguChek® monitoring systems empower healthcare professionals to make immediate, knowledge-based adjustments of anticoagulation therapy with minimum inconvenience to their patients:

CoaguChek® testing at the point of care for:

  • Better patient care and quality of life1,2
  • Optimised healthcare workflows
  • Anticoagulation therapy for patient subgroups with special conditions
    • Patients with severe renal impairment3
    • Patients with increased risk of bleeding and gastrointestinal side effects
    • Patients with mechanical heart valves at high risk of stroke 3,4

 

Discover our products:



References:

  1. onitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367:404-411
  2. Wann LS, et al. 2011 ACCF/AHA/HRS A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;57:1330-1337
  3. Fuster V, et al: 2011 ACCF/AHA/HRS focused updates incorporated into the ADDF/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of CardiologyFoundation/American Heart Association task force on practice guidelines. Circulation 2011;123:269-367
  4. Connolly SJ,et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-1151